FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/11/038339 [Registered on: 30/11/2021] Trial Registered Prospectively
Last Modified On: 18/06/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Physiotherapy (Not Including YOGA) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Treatment of the weakness of Upper Extremity due to Stroke by virtual gaming 
Scientific Title of Study   A Comprehensive Framework for Treatment of Impairment of Upper Extremity due to Stroke by Combining Computational Modeling and Virtual Reality 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr P N Sylaja 
Designation  Professor of Neurology 
Affiliation  Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram 
Address  Comprehensive Stroke Care Program, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Medical College Campus, Thiruvananthapuram

Thiruvananthapuram
KERALA
695011
India 
Phone  04712524482  
Fax    
Email  sylajapn@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr P N Sylaja 
Designation  Professor of Neurology 
Affiliation  Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram 
Address  Comprehensive Stroke Care Program, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Medical College Campus, Thiruvananthapuram

Thiruvananthapuram
KERALA
695011
India 
Phone  04712524482  
Fax    
Email  sylajapn@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr P N Sylaja 
Designation  Professor of Neurology 
Affiliation  Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram 
Address  Comprehensive Stroke Care Program, Sree Chitra Tirunal Institute for Medical Sciences and Technology, Medical College Campus, Thiruvananthapuram

Thiruvananthapuram
KERALA
695011
India 
Phone  04712524482  
Fax    
Email  sylajapn@hotmail.com  
 
Source of Monetary or Material Support  
Indian Council of Medical Research 
Ministry of Human Resource Development 
Tata Consultancy Services 
 
Primary Sponsor  
Name  Indian Council of Medical Research 
Address  V. Ramalingaswami Bhawan, P.O. Box No. 4911 Ansari Nagar, New Delhi - 110029, India 
Type of Sponsor  Government funding agency 
 
Details of Secondary Sponsor  
Name  Address 
Ministry of Human Resource Development  122-C, Shastri Bhawan New Delhi - 110001 
Tata Consultancy Services  TCS House, Raveline Street, Fort Mumbai 400 001, India 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Srijithesh PR  National Institute of Mental Health and Neurosciences  Department of Neurology, Hosur Road, Hombegowda Nagar, Bengaluru, Karnataka 5600029
Bangalore
KARNATAKA 
08026995905

srijitheshpr@gmail.com 
Dr P N Sylaja  Sree Chitra Tirunal Institute for Medical Sciences and Technology  Room No. 3109, Comprehensive Stroke Care Program, Department of Neurology, Medical College Campus, Thiruvananthapuram - 695 011, Kerala, India.
Thiruvananthapuram
KERALA 
04712524482

sylajapn@hotmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institutional Ethics Committee, Sree Chitra Tirunal Institute for Medical Sciences and Technology  Approved 
Institutional Ethics Committee,National Institute of Mental Health and Neurosciences  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I63||Cerebral infarction,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Physiotherapy  Routine Physiotherapy for 3 months (Standard of care) 
Intervention  Virtual Gaming  Virtual gaming will be given minimum of 3 sessions/week for 3 months 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  (a) Age between 18-70 years of age
(b) Patients with first-ever stroke with impairment of upper limb extremity function
(c) Time of stroke onset between 1-6 months
(d) Level of spasticity in upper extremity between grades 1 and 1+ based on Modified Ashworth scale
(e) Brunnstrom hand recovery stages of 4,5,6, shoulder and elbow recovery stages of 3,4,5 
 
ExclusionCriteria 
Details  1. Age<18 years
2. Other neurological disorders that cause motor deficits, such as Parkinson’s disease and peripheral neuropathy;
3. Severe aphasia resulting in communication difficulties that could influence the intervention and outcome measures;
4. Cognitive impairment resulting in cooperation difficulties (a score of≤24 in the Mini-Mental State Examination);
5. Severe pain impeding upper extremity rehabilitation (numeric pain rating scale score ≥ 7)
6. No significant visual dysfunction.
7. Contraindications for doing MRI.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Centralized 
Blinding/Masking   Open Label 
Primary Outcome
Modification(s)  
Outcome  TimePoints 
Feasibility Outcome: Compliance with the treatment

Efficacy Outcome: Fugl Meyer score and Wolf motor function test

 
Feasibility Outcome: 3 months

Efficacy Outcome: Baseline and 3 months 
 
Secondary Outcome
Modification(s)  
Outcome  TimePoints 
Barthel Index (BI) & Quality of life scale (SF-36)  Baseline & 3 months 
 
Target Sample Size   Total Sample Size="162"
Sample Size from India="162" 
Final Enrollment numbers achieved (Total)= "66"
Final Enrollment numbers achieved (India)="66" 
Phase of Trial   N/A 
Date of First Enrollment (India)   27/12/2021 
Date of Study Completion (India) 11/07/2024 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response (Others) -  Proposals should be directed to sylajapn@hotmail.com

  6. For how long will this data be available start date provided 07-11-2025 and end date provided 06-11-2028?
    Response - Beginning 9 months and ending 36 months following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - Nil
Brief Summary  

The proposed project is to build a comprehensive, large-scale computational neural model of the key parts of the brain involved in the control of upper extremities. The model must simulate the effects of specific stroke lesions and their effects on arm movements. The model allows customization to a given patient based on measurements of the site, location, disruption in the structure-function relation in the stroke-afflicted brain. Proposed treatment modalities will be first simulated on the model, and only the most effective solutions will be administered to the patient. The use of such large-scale, comprehensive computational models for the treatment of neurological disease can be a game-changer in clinical neuroscience. It has the potential to transform the current empirical traditions of clinical neurology, into a quantitative, data and model-driven, scientific practice.

The objectives of the project is

  1. Development of the large-scale, computational neuroscience model:
  2. Movement analysis and modeling:
  3. Development of Virtual Reality-based Gaming system
  4. Clinical: Evaluating the feasibility and efficacy of virtual reality-based gaming in stroke survivors with impairment of the upper extremity
  5. Neuroimaging: Measurement of pre-treatment and post-treatment recovery process in the  function of the brain using resting-state functional imaging studies

Hypothesis: The hypothesis for our study is that the proposed VR gaming-based rehabilitation scheme gives better clinical outcomes than a comparable traditional rehabilitation scheme. Combined with the computational modeling effort, it is expected that we can bridge the gaps in terms of characterizing, on the one hand, the relation between VR gaming parameters and the behavioral improvements and on the other hand probe the neural substrates of these improvements. It is also envisaged that the computational models allow us to customize the therapies for individual patients.

Study Methodology: In the patients who fulfill the inclusion criteria, informed consent will be taken and then baseline NIHSS, Wolf motor function test, Fugl Meyer score for upper limb will be done. In addition, a quality-of-life scale - SF 36, mRS, and Barthel Index will be done. Following this patients will be randomized either to intervention or control group using the software. Then they undergo MRI brain protocol which includes resting-state functional MRI which will be done at baseline and after 12 weeks of therapy.

Each arm will receive the therapy for 12 weeks, 3 sessions per week. Each session will be for 30-45 minutes each. The conventional arm will receive routine therapy for strengthening and functional activities and the intervention arm will receive training on virtual reality-based gaming. A repeat assessment of the Wolf motor function test, Fugl Meyer score for upper limb, quality of life assessment mRS, and Barthel Index will be done at the end of 3 months. In addition,10  healthy controls will undergo MRI brain protocol including resting-state functional MRI which will be important for the modeling.

 
Close